Literature DB >> 12454704

Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.

Hale Oren1, Sermin Ozkal, Hüseyin Gülen, Murat Duman, Canan Uçar, Berna Atabay, Sebnem Yilmaz, Aydanur Kargi, Gülersu Irken.   

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a rare disease occurring in childhood. Recently, it has been shown that heritable mutations in Fas or Fas ligand genes, which regulate lymphocyte survival by triggering apoptosis of lymphocytes, are the most frequent cause of ALPS. Patients with ALPS frequently have lymphadenopathy, splenomegaly and hepatomegaly, especially at young ages. A positive result of the Direct Coomb's test, autoimmune hemolytic anemia, and idiopathic thrombocytopenic purpura are the most common features of autoimmunity in patients with ALPS. Elevated numbers and percentages (>1%) of double-negative (CD4-CD8-) T cells, and characteristic pathologic findings in lymph nodes or spleen are other important diagnostic features. In this report, we present the clinical, immunologic, and pathologic features of two children who were diagnosed with ALPS. The early recognition of ALPS in children with enlarged lymph nodes, hepatosplenomegaly, and autoimmune hematologic features has important diagnostic and prognostic value in avoiding expensive and time-consuming studies and unnecessary treatments. The ratio of CD4-CD8- T cells, immunoglobulin levels and the histopathologic features of lymph nodes should be rapidly determined in these patients in order to establish an early diagnosis and treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12454704     DOI: 10.1007/s00277-002-0537-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Systemic onset juvenile rheumatoid arthritis presenting with absence of B lymphocytes.

Authors:  Hasibe Artac; Hayrullah Alp; Sevgi Keles; Ismail Reisli; Recep Tunc
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 2.631

2.  [Inflammatory reactions of the spleen].

Authors:  T Rüdiger; M Hartmann; H K Müller-Hermelink; A Marx
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.